Taysha Gene Therapies Inc GAN Program Acquisition Call Transcript
Greetings, and welcome to Taysha Gene Therapy's GAN Program Acquisition Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded today, April 12, 2021.
I will now turn the call over to Dr. Kimberly Lee, Senior Vice President of Corporate Communications and Investor Relations. Please go ahead.
Thank you. Good morning, and welcome to Taysha's GAN Program Acquisition Conference Call. Joining me on today's call are RA Session II, Taysha's President, CEO and Founder; and Dr. Suyash Prasad, Chief Medical Officer and Head of R&D; Dr. Steven Gray, Chief Scientific Adviser at Taysha and Associate Professor in the Department of Pediatrics at UT Southwestern; Kamran Alam, Chief Financial Officer; and Fred Porter, Chief Technical Officer, will join us for the question-and-answer session.
Earlier today, Taysha issued a press release announcing the acquisition of exclusive worldwide rights to TSHA-120 for the treatment of GAN,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |